PMID: 7032378Jan 1, 1982Paper

Steroid response in stable chronic obstructive pulmonary disease

Annals of Internal Medicine
L A MendellaN R Anthonisen

Abstract

We compared a 2-week course of 32 mg/d methylprednisolone with placebo in a double-blind crossover trial in 46 well-characterized patients with stable chronic obstructive pulmonary disease. Placebo and steroid trials were separated by 2 weeks when no tablets were given. Response was assessed by measuring forced expiratory volume in 1 second (FEV1.0). Placebo responses were normally distributed (mean, 0.8% change in FEV1.0; range, -30% to 33%). Six patients showed a greater than 50% increase of FEV1.0 in response to steroid; a seventh showed a 36% increase and an eighth, a 29% increase. Because of these patients the group as a whole showed a significantly greater FEV1.0 after steroid than after placebo. The eight steroid responders did not differ from nonresponders in age, sex, smoking history, or duration and intensity of symptoms including wheeze. Baseline lung function and eosinophilia of blood or sputum did not differ between the two groups. Patients who responded to steroids also responded to inhaled beta agonists: Acute bronchodilator response averaged 25% in steroid responders and 13% in nonresponders, a difference that was statistically significant although there was overlap between the two groups.

Citations

Dec 1, 1996·The Annals of Thoracic Surgery·M ArgenzianoM E Ginsburg
Jul 28, 1984·Lancet·D M MitchellJ V Collins
Mar 25, 1999·The New England Journal of Medicine·G W Smetana
Feb 27, 2001·Current Opinion in Pulmonary Medicine·D E Niewoehner
Dec 1, 1994·Journal of Internal Medicine·H O Conn, T Poynard
Sep 25, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·David W ReidE Haydn Walters
Sep 30, 1984·La Clinica terapeutica·R Rudd
Apr 1, 1998·American Journal of Respiratory and Critical Care Medicine·P J BarnesW W Busse
Nov 17, 1998·American Journal of Respiratory and Critical Care Medicine·E PizzichiniF E Hargreave
Jul 21, 2000·American Journal of Respiratory and Critical Care Medicine·K L RiceD E Niewoehner
Jun 19, 2002·American Journal of Respiratory and Critical Care Medicine·Keith L HattotuwaNeil C Barnes
Oct 29, 2010·Annals of Thoracic Medicine·Fahad A Al-Ghimlas, Andrew McIvor
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Richard Wood-Baker
Dec 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·D M Newnham
Jun 1, 1996·Chest·D P Joyce
May 1, 1995·Chest·J Ramsdell
May 1, 1996·Chest·T E RenkemaD S Postma
Jan 30, 1999·Chest·N R Anthonisen
Jun 11, 1998·Mayo Clinic Proceedings·J P UtzC Deschamps
Dec 20, 2007·Oral and Maxillofacial Surgery Clinics of North America·Rana Y Ali, M Scott Reminick
Nov 14, 1986·The American Journal of Medicine·M S Skorodin
Oct 21, 1991·The American Journal of Medicine·K R Chapman
Sep 1, 1987·Kokyu to junkan. Respiration & circulation·K HosakaY Fukushima
Apr 1, 1985·European Journal of Cancer & Clinical Oncology·J Aisner, M Chatham
Sep 1, 1994·Respiratory Medicine·R IsoahoE Tala

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.